Journal of Clinical and Diagnostic Research (May 2021)

Critical Level of Alanine Transaminase to Predict Foetomaternal Outcome in Intrahepatic Cholestasis of Pregnancy: A Case-control Study

  • Nidhi Ahuja,
  • Anjali Dabral,
  • Sheeba Marwah,
  • Rekha Bharti,
  • Deepti Pachauri,
  • Jyotsna Suri

DOI
https://doi.org/10.7860/JCDR/2021/49078.14904
Journal volume & issue
Vol. 15, no. 5
pp. QC01 – QC05

Abstract

Read online

Introduction: Intrahepatic Cholestasis of Pregnancy (IHCP) is a disorder of the second and third trimester causing pruritis without a rash in the women. To avoid the adversities, early delivery is indicated before serum bile acids levels of >40 µmol/L is reached. In the settings where bile acid testing is not available, serum transaminases can be used for diagnosis and management of IHCP. Aim: To find out value of Alanine Transaminase (ALT) for the prediction of adverse outcomes. Materials and Methods: This case-control study was carried out from October 2018 to March 2020, enrolled 75 singleton women with IHCP and 75 controls in their third trimester. The diagnosis was based on the presence of pruritis without an identifiable dermatological cause along with raised serum transaminases. Serum ALT levels and the foetomaternal outcomes were noted. Statistical analysis was done using Statistical Package for Social Sciences (SPSS) version 21.0. Mann-Whitney test, Chi-square test and Fisher’s exact test were used to compare all variables. The p-value of 133 U/L is predictive of adverse foetal outcome, therefore, termination of pregnancy can be advocated above this level.

Keywords